DE181258C - - Google Patents
Info
- Publication number
- DE181258C DE181258C DENDAT181258D DE181258DA DE181258C DE 181258 C DE181258 C DE 181258C DE NDAT181258 D DENDAT181258 D DE NDAT181258D DE 181258D A DE181258D A DE 181258DA DE 181258 C DE181258 C DE 181258C
- Authority
- DE
- Germany
- Prior art keywords
- mercury
- oxycyanide
- solution
- acoin
- injections
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000243 solution Substances 0.000 claims description 11
- CDTQFWQRRNQQCL-UHFFFAOYSA-N cyano cyanate;mercury Chemical compound [Hg].N#COC#N CDTQFWQRRNQQCL-UHFFFAOYSA-N 0.000 claims description 10
- ZQWBGSZBBGYKNV-UHFFFAOYSA-N 2-(4-ethoxyphenyl)-1,3-bis(4-methoxyphenyl)guanidine;hydrochloride Chemical compound Cl.C1=CC(OCC)=CC=C1N=C(NC=1C=CC(OC)=CC=1)NC1=CC=C(OC)C=C1 ZQWBGSZBBGYKNV-UHFFFAOYSA-N 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims 1
- 239000007924 injection Substances 0.000 description 5
- 210000003491 Skin Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drugs Drugs 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000031711 Cytophagaceae Species 0.000 description 1
- 208000006922 Drug-Related Side Effects and Adverse Reaction Diseases 0.000 description 1
- 241001043632 Fleroya Species 0.000 description 1
- 208000006379 Syphilis Diseases 0.000 description 1
- 230000003444 anaesthetic Effects 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 150000002730 mercury Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
KAISERLICHESIMPERIAL
PATENTAMT.PATENT OFFICE.
PATENTSCHRIFTPATENT LETTERING
- JKl 181258'-KLASSE 30 h. GRUPPE - JKl 181258'- CLASS 30 h. GROUP
Dr. GEORG HIRSCH in HALBERSTADT.Dr. GEORG HIRSCH in HALBERSTADT.
Die Heilkunde benutzt das Quecksilberoxycyanid (Hydrargyrum oxycyanatum) in etwa einprozentiger· wäßriger Lösung zu Einspritzungen unter die Haut zum Zwecke der Syphilisbehandlung. Diese Einspritzungen sind aber, wie alle ähnlichen, mehr oder minder schmerzhaft. Es sind nun bereits Vorschläge gemacht worden, schmerzhafte Nebenwirkungen von Arzneimitteln durchMedicine uses mercury oxycyanide (Hydrargyrum oxycyanatum) in about one percent aqueous solution for injections under the skin for the purpose of Syphilis treatment. These injections are, like all similar ones, more or more less painful. Proposals have now been made, painful ones Side effects of drugs
ίο Mitbenutzung anästhesierender Mittel zu beseitigen (zu vergl. das Buch »Arzneistoffe der chemischen Fabrik von Heyden« 1903, Seite 32, und »Pharmazeutische Zentralhallea, 40, 1899, Heft 5, Seite 69, Spalte 2, Mitte).ίο Eliminate shared use of anesthetic agents (cf. the book "Drugs of the Chemical Factory of Heyden" 1903, Page 32, and »Pharmaceutical Central Hallea, 40, 1899, issue 5, page 69, column 2, middle).
Sucht man die Schmerzhaftigkeit von Quecksilberoxycyanidinjektionen durch Zusatz von Acoin, einem von der chemischen Fabrik von Heyden hergestellten Anästhetikum, zu den Quecksilberoxycyanidlösungen zu beseitigen,One looks for the painfulness of mercury oxycyanidine injections by adding Acoin, an anesthetic made by the Heyden Chemical Factory, to the Eliminate mercury oxycyanide solutions,
so ergibt sich der Übelstand, daß Quecksilberoxycyanidlösung und Acoinlösung sich ohne weiteres nur vermischen lassen, so lange man sehr schwache Lösungen von Quecksilberoxycyanid (1 : 1000 oder mehr) benutzt; in einprozentiger Lösung von Quecksilberoxycyanid dagegen bildet Acoin sofort einen Niederschlag, so daß das Gemisch nicht benutzbar ist.so there is the problem that mercury oxycyanide solution and acoin solution are mutually exclusive Just let them mix without further ado as long as you have very weak solutions of mercury oxycyanide (1: 1000 or more) used; in one percent solution of mercury oxycyanide on the other hand, Acoin immediately forms a precipitate, making the mixture unusable is.
Es wurde nun gefunden, daß, wenn man die Quecksilberoxycyanidlösung schwach ansäuert, z. B. etwa 5 Tropfen Salzsäure zu je 100 g starker Quecksilberoxycyanidlösung fügt, sich diese mit wäßriger, ζ. Β. einprozentiger, Acoinlösung ohne Trübung mischt. Auf diese Weise lassen sich zu antisyphilitischen Einspritzungen unter die Haut Mischungen von Quecksilberoxycyanidlösung mit Acoinlösung herstellen. Diese Quecksilbereinspritzung erzeugt keine Schmerzen.It has now been found that if the mercury oxycyanide solution is weakly acidified, z. B. about 5 drops of hydrochloric acid per 100 g of strong mercury oxycyanide solution blends this with watery, ζ. Β. one percent, acoin solution mixes without cloudiness. In this way, anti-syphilitic injections can be made under the skin of mercury oxycyanide solution with acoin solution. This mercury injection does not cause pain.
4040
Claims (1)
Publications (1)
Publication Number | Publication Date |
---|---|
DE181258C true DE181258C (en) |
Family
ID=445455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DENDAT181258D Active DE181258C (en) |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE181258C (en) |
-
0
- DE DENDAT181258D patent/DE181258C/de active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MILLER et al. | The effect of renal failure and hyperkalemia on the duration of pancuronium neuromuscular blockade in man | |
DE181258C (en) | ||
Ghoneim et al. | The interaction between d-tubocurarine and gallamine during halothane anaesthesia | |
De Silva | Magnesium intoxication: an uncommon cause of prolonged curarization | |
Harnik | A study of the biphasic ventilatory effects of propanidid | |
HIRSCH et al. | Intracarotid route in the treatment of general paresis | |
DE2633891A1 (en) | NEW SALT OF ALPHA-METHYLBENZOYL-5-THIOPHEN-2-ACETIC ACID, PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS | |
DE1197193B (en) | Process for the preparation of injectable aqueous solutions of acetylsalicylic acid | |
Levene | Darstellung und Analyse einiger Nucleinsäuren: VIII. Mitteilungen über die Milznucleinsäure | |
Underhill et al. | The Excretion of Arsenic After Serial Administration of Arsphenamin and Neo-Arsphenamin | |
Doll et al. | The effect of paludrine on human gastric secretion | |
Wong et al. | Some synergistic effects of d-tubocurarine and gallamine | |
DE1668563C3 (en) | Cer (III) -L (+) - lactate, process for its production and pharmaceutical preparations containing it | |
DE2949707C2 (en) | Aqueous medicament solutions of diphenylmethylpiperazine derivatives which can be administered parenterally | |
Stillman | Chemistry in medicine in the fifteenth century | |
DE3979C (en) | Process for the preparation of a soluble mercury albuminate | |
DE897907C (en) | Process for the preparation of injection solutions which do not flocculate with serum or blood | |
DE2752339C3 (en) | Drugs with a depot effect for the treatment of breast cancer | |
DE398118C (en) | Process for the preparation of emulsoid medicinal fluids containing ethereal oils | |
SU1173989A1 (en) | Method of diagnosis of multiple sclerosis | |
DE154548C (en) | ||
DE317509C (en) | ||
DE111759C (en) | ||
HEIMBURGER | Treatment of leprosy in Tsinan Leper Hospital | |
Schussler Jr | A PLAN FOR THE INTENSIVE TREATMENT OF CONGENITAL SYPHILIS: PRELIMINARY REPORT |